FTC Warns REMS Abuse Not Safe From Antitrust Law
The Federal Trade Commission warned in an amicus filing in New Jersey federal court Tuesday that generic-drug makers should be allowed to sue brand-name companies under antitrust laws for allegedly gaming...To view the full article, register now.
Already a subscriber? Click here to view full article